Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.
-
07:30 ET
ESSA Pharma Enhances R&D Capabilities with Two New Key Hires
HOUSTON and VANCOUVER, April 24, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company...
-
07:00 ET
Delivra successfully demonstrates targeted pain relief with topical ibuprofen
TSXV: DVA TORONTO, April 24, 2018 /CNW/ - Delivra Corp. ("Delivra", or "the Company") today announced the ability to treat pain directly with a...
-
01:37 ET
Connect Biopharmaceuticals Advances CBP-201, a Novel Monoclonal Antibody Against IL-4Rα, Into Clinical Development
Connect Biopharmaceuticals, Ltd. today announced that it has submitted an application in Australia to begin a phase 1 clinical trial to evaluate...
-
Apr 23, 2018, 08:00 ET
Canada's Cannabis Industry Unites to Create the Cannabis Canada Council: Names New Board and Appoints Executive Director
OTTAWA, April 23, 2018 /CNW/ - The Cannabis Canada Association (CCA), Canadian Medical Cannabis Council (CMCC), as well as Canopy Growth...
-
Apr 20, 2018, 09:00 ET
Indivior Announces New Drug Submission to Health Canada for SUBLOCADE™ (Buprenorphine Extended-Release) Injection for the Treatment of Moderate to Severe Opioid Use Disorder
Indivior PLC (LON: INDV) today announced that it has filed a New Drug Submission (NDS) with Health Canada's Therapeutic Drugs Directorate for...
-
Apr 19, 2018, 19:38 ET
ESSA Pharma Inc. Announces Share Consolidation
HOUSTON and VANCOUVER, April 19, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage...
-
Apr 19, 2018, 09:43 ET
Statement - National Pharmacare should ensure access to medicines for all
OTTAWA, April 19, 2018 /CNW/ - The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. "Innovative...
-
Apr 18, 2018, 09:05 ET
Swift Biosciences Launches Accel-Amplicon Plus Cancer Panels for Precision Medicine Initiatives
Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus™ Cancer NGS Panels, a suite of nine tumor-specific and focused...
-
Apr 18, 2018, 07:00 ET
Delivra Publishes Pivotal Results on the Cholesterol & Lipid Lowering Agent Berberine
TSXV: DVA TORONTO, April 18, 2018 /CNW/ - Delivra Corp. ("Delivra", or "the Company") today announced the publication of positive data from a...
-
Apr 17, 2018, 19:49 ET
RMR Science Technologies Inc. Announces Qualifying Transaction with cannÖgen Biosciences Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN...
-
Apr 17, 2018, 07:00 ET
Sierra Late-Breaking Data Demonstrating SRA737 Preclinical Activity with PARPi to be Presented at the AACR 2018 Annual Meeting
- Two posters reporting activity for SRA737 with PARPi (in CCNE1-driven cancers, HRR proficient cancers, and PARPi-resistant cancers) reinforce the...
-
Apr 17, 2018, 06:48 ET
Sotera Health LLC announces intent to sell Nordion's Medical Isotopes segment to BWXT
Sotera Health LLC, the world's leading, fully integrated protector of global health, today announced that it has entered into a definitive asset...
-
Apr 17, 2018, 05:30 ET
Exploratory IND Is Planned Using GB Sciences' Proprietary Mixtures of Botanical Compounds to Provide the Highest Efficacy for Patients
GB Sciences, Inc. (OTCQB: GBLX), as previously reported, plans to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable...
-
Apr 16, 2018, 18:22 ET
JHL Biotech's Clinical Trial Application Accepted by China for Bevacizumab Biosimilar to Treat Colorectal, Lung, and Ovarian Cancers
JHL Biotech announced today that the China Food and Drug Administration (CFDA) has accepted for review JHL's Clinical Trial Application for a...
-
Apr 16, 2018, 09:22 ET
/R E P E A T -- Beleave Receives Sales License from Health Canada/
TORONTO, April 13, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that its wholly-owned...
-
Apr 16, 2018, 07:00 ET
MedReleaf adds PINs to its medical cannabis products to facilitate coverage and reimbursement under drug benefit plans
MARKHAM, ON, April 16, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company"), Canada's first and only ISO 9001 and ICH-GMP...
-
Apr 13, 2018, 17:01 ET
Beleave Receives Sales License from Health Canada
TORONTO, April 13, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that its wholly-owned...
-
Apr 12, 2018, 08:49 ET
MedReleaf completes 164 acre property and 1 million square foot greenhouse acquisition
Fourfold capacity expansion supports future adult-use demand and international growth MARKHAM, ON, April 12, 2018 /CNW/ - MedReleaf Corp....
-
Apr 12, 2018, 07:00 ET
Restorative Breast Cancer Solution Start-Up Wins the 2018 FACIT Pitch Competition
Biotechnology competition modeled after popular TV program Dragons' Den TORONTO, April 12, 2018 /CNW/ - A panel of investor-judges has selected...
-
Apr 12, 2018, 06:30 ET
Prometic Presents New PBI-4050 Clinical Data From Ongoing Alström Syndrome Phase 2 Trial
- New clinical data presented at the International Liver CongressTM 2018 - PBI-4050 decreased insulin resistance in the liver -...